Scouting Cell & Gene Therapy Technologies for CKD

Client Success Details

Our analysis methodology involved a blend of knowledge harvesting, insights generation, patent literature exploration, and primary executive discussions. This multifaceted approach enabled the client to identify the scientific evidence for the safety and efficacy of cell therapies, discover the entities actively working in this domain, comprehend the procedure and mechanism of action of identified cell and gene therapies for CKD, and determine the maturity level of these therapies. The study addressed several crucial business questions, including:

Recent advancements in Cell & Gene Therapies offer promise for chronic conditions like CKD, but identifying the right players and technologies in a rapidly evolving sector is a challenge.

What is the landscape of current and emerging cell and gene therapies being assessed for CKD treatment? What is the entity ecosystem of active players providing these breakthrough therapies? Who are the new entrants in this domain, and how is the landscape projected to evolve in the next few years?

• What scientific evidence, either preclinical or clinical data, is available publicly to vouch for the efficacy of cell and gene therapy in kidney repair?
• What are the cell and gene therapies for CKD treatment during the pre-dialysis stage in humans?
• How are the cell and gene therapies for CKD administered?
• Which other therapeutic areas are targeted by the identified cell and gene therapies for CKD?
• Who are the significant players actively investigating novel cell and gene therapies for CKD?
• What recent collaborations, mergers, acquisitions, etc., are associated with these key players?
• How are academia and startups in this domain funded?
• What does the IP portfolio of these entities look like for such therapies?
• Who are the new entrants and how is the landscape expected to evolve in the next few years in the segment?

Our process comprised of:

• Insights Gathering: Engaging with technology-specific portals, blogs, journals, and expert opinion sites to gather insights.
• Patent Analysis: Conducting detailed patent analysis using databases such as QuestelOrbit, USPTO, Espacenet, etc.
• Literature Review: Reviewing scientific journals and publications from Web of Science, PubMed, and Science Direct for comprehensive insights.
• Stakeholder Engagement: Initiating discussions with potential partners (12 entities) to explore collaboration opportunities and gather strategic insights.

We helped the client gain valuable insights into the current landscape and future potential of cell and gene therapies in the CKD segment and empowered their R&D and strategic teams, allowing them to make well-informed decisions in their pursuit of innovative CKD treatments.

Engage with us to explore innovative Cell & Gene Therapies for chronic kidney disease (CKD) solutions customized to support novel treatments and maturity levels of therapies.